Exploring Biofilm Inhibition Potential of Imidazo‐Pyridine Linked Tetrazoles Against Candida albicans : Synthesis, Biological Evaluation With Computational Studies
Chemical Biology & Drug Design · 2026-07 · 108 (1)
DOI: 10.1111/cbdd.70359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 16.07.2026. Verfasst von Madalambika und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Studies in Chemistry, Manasagangotri, University of Mysore, Mysuru, Karnataka, India. Hauptthemen laut MEDLINE: Candida albicans, Biofilms, Antifungal Agents, Tetrazoles. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Karnataka Science and Technology Promotion Society (KSTePS), DST Ph.D. Fellowship Programme..
Abstract (Originalsprache)
Infectious diseases remain one of the major global health challenges due to their rapid transmission and evolving pathogenic mechanisms. Among them, Candida albicans has emerged as a significant opportunistic antifungal pathogen, which is responsible for biofilm‐associated infections. In the present study, a library of new tetrazole bearing imidazo‐pyridine molecules (4a–4j) was synthesised and characterised through spectroscopic techniques ( 1 H, 13 C and MS) for structural confirmation. Their in vitro antifungal potential was evaluated against C. albicans , where compound 4d emerged as the most promising lead among all by exhibiting a MIC of 7 μg/mL and MFC of 45 μg/mL, conquering the reference fluconazole (FLC) which showed 8 μg/mL and 64 μg/mL of MIC and MFC, respectively. Compound 4d also demonstrated 75% and 86% inhibition of fungal filamentation and of biofilm formation, respectively. qRT‐PCR analysis confirmed the significant downregulation of important virulence genes, and SEM imaging further validated biofilm prevention. Toxicity assessment through hemolytic and cytotoxic assays on HEK293 cell line indicated low toxicity across tested concentrations. Additionally, computational evaluation including molecular docking and ADMET parameters supported the predicted binding affinities and pharmacokinetic properties of the synthesised compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Studies in Chemistry, Manasagangotri, University of Mysore, Mysuru, Karnataka, India.
- Department of Biotechnology and Bioinformatics, School of Life Sciences, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India.
ORCID-Profile: A C Kumar, P M BharathKumar, Ramith Ramu, Nagaraja Naik
Förderung
- Karnataka Science and Technology Promotion Society (KSTePS), DST Ph.D. Fellowship Programme.
Zitieren
APA
Madalambika, Kumar, A. C., BharathKumar, P. M., Gowda, K. B. V., Ramu, R., & Naik, N. (2026). Exploring Biofilm Inhibition Potential of Imidazo‐Pyridine Linked Tetrazoles Against Candida albicans : Synthesis, Biological Evaluation With Computational Studies. Chemical Biology & Drug Design, 108(1). https://doi.org/10.1111/cbdd.70359
Vancouver
Madalambika, Kumar AC, BharathKumar PM, Gowda KBV, Ramu R, Naik N. Exploring Biofilm Inhibition Potential of Imidazo‐Pyridine Linked Tetrazoles Against Candida albicans : Synthesis, Biological Evaluation With Computational Studies. Chemical Biology & Drug Design. 2026;108(1). doi:10.1111/cbdd.70359
BibTeX
@article{Madalambika2026,
author = {Madalambika and Kumar, A C and BharathKumar, P M and Gowda, K B Vilas and Ramu, Ramith and Naik, Nagaraja},
title = {Exploring Biofilm Inhibition Potential of Imidazo‐Pyridine Linked Tetrazoles Against Candida albicans : Synthesis, Biological Evaluation With Computational Studies},
journal = {Chemical Biology & Drug Design},
year = {2026},
volume = {108},
number = {1},
doi = {10.1111/cbdd.70359}
}
EUVIMED